A Study to Evaluate Safety, Pharmacokinetics, and Clinical Activity of Combination of RO6870810 and Venetoclax, With or Without Rituximab, in Participants With Relapsed/Refractory DLBCL and/or High-Grade B-Cell Lymphoma and/or High Grade B-Cell
about
A Study to Evaluate Safety, Pharmacokinetics, and Clinical Activity of Combination of RO6870810 and Venetoclax, With or Without Rituximab, in Participants With Relapsed/Refractory DLBCL and/or High-Grade B-Cell Lymphoma and/or High Grade B-Cell
description
clinical trial
@en
klinisch onderzoek
@nl
name
A Study to Evaluate Safety, Ph ...... phoma and/or High Grade B-Cell
@en
type
label
A Study to Evaluate Safety, Ph ...... phoma and/or High Grade B-Cell
@en
prefLabel
A Study to Evaluate Safety, Ph ...... phoma and/or High Grade B-Cell
@en
P17
P1050
P1476
Open-Label, Dose Escalation/Ex ...... nd/or BCL6 Gene Rearrangements
@en
P3098
NCT03255096
P4844
P580
2017-08-28T00:00:00Z
P582
2020-03-26T00:00:00Z